2-165748461-C-CTA

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_004482.4(GALNT3):​c.*318_*319dupTA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000452 in 343,188 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00034 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00054 ( 0 hom. )

Consequence

GALNT3
NM_004482.4 3_prime_UTR

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.300

Publications

0 publications found
Variant links:
Genes affected
GALNT3 (HGNC:4125): (polypeptide N-acetylgalactosaminyltransferase 3) This gene encodes UDP-GalNAc transferase 3, a member of the GalNAc-transferases family. This family transfers an N-acetyl galactosamine to the hydroxyl group of a serine or threonine residue in the first step of O-linked oligosaccharide biosynthesis. Individual GalNAc-transferases have distinct activities and initiation of O-glycosylation is regulated by a repertoire of GalNAc-transferases. The protein encoded by this gene is highly homologous to other family members, however the enzymes have different substrate specificities. [provided by RefSeq, Jul 2008]
GALNT3 Gene-Disease associations (from GenCC):
  • tumoral calcinosis, hyperphosphatemic, familial, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • tumoral calcinosis, hyperphosphatemic, familial, 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004482.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNT3
NM_004482.4
MANE Select
c.*318_*319dupTA
3_prime_UTR
Exon 11 of 11NP_004473.2Q14435-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNT3
ENST00000392701.8
TSL:1 MANE Select
c.*318_*319dupTA
3_prime_UTR
Exon 11 of 11ENSP00000376465.3Q14435-1
GALNT3
ENST00000409882.5
TSL:1
c.*318_*319dupTA
3_prime_UTR
Exon 8 of 8ENSP00000386955.1E7EUL0
GALNT3
ENST00000902717.1
c.*318_*319dupTA
3_prime_UTR
Exon 11 of 11ENSP00000572776.1

Frequencies

GnomAD3 genomes
AF:
0.000351
AC:
53
AN:
151164
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000243
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000792
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000387
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00323
Gnomad NFE
AF:
0.000458
Gnomad OTH
AF:
0.000484
GnomAD4 exome
AF:
0.000537
AC:
103
AN:
191914
Hom.:
0
Cov.:
0
AF XY:
0.000607
AC XY:
59
AN XY:
97272
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000327
AC:
2
AN:
6124
American (AMR)
AF:
0.000456
AC:
3
AN:
6578
Ashkenazi Jewish (ASJ)
AF:
0.000266
AC:
2
AN:
7514
East Asian (EAS)
AF:
0.00
AC:
0
AN:
15074
South Asian (SAS)
AF:
0.000450
AC:
9
AN:
19990
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6576
Middle Eastern (MID)
AF:
0.00346
AC:
3
AN:
868
European-Non Finnish (NFE)
AF:
0.000650
AC:
76
AN:
117006
Other (OTH)
AF:
0.000657
AC:
8
AN:
12184
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.362
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000344
AC:
52
AN:
151274
Hom.:
0
Cov.:
32
AF XY:
0.000298
AC XY:
22
AN XY:
73882
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41332
American (AMR)
AF:
0.000791
AC:
12
AN:
15176
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.000388
AC:
2
AN:
5160
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4792
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10408
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.000458
AC:
31
AN:
67656
Other (OTH)
AF:
0.000479
AC:
1
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000108
Hom.:
0
Bravo
AF:
0.000329

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.30
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140333197; hg19: chr2-166604971; API